SU‐GG‐T‐427: Dose Painting to Combat Tumor Hypoxia While Sparing Urethra in Prostate IMRT: A Biologically‐Based Adaptive Approach Accounting for Setup Uncertainties and Organ Motion

Purpose: To explore means of incorporating prostate motion and setup uncertainties into biologically‐based adaptive IMRT optimization for Volumetric Modulated Arc Therapy (VMAT). Method and Materials:IMRT planning objectives were set to produce a dose distribution, which, after accounting for setup uncertainties and prostate motion, meets the following requirements. 1) The CTV is covered with the desired dose; 2) Hypoxia volumes arbitrarily drawn inside CTV are boosted; 3) Desired urethra sparing is achieved. The objective function was based on equivalent uniform dose (EUD). Repositioning data from five prostate patients with implanted fiducial markers were used. Systematic and random uncertainties for each patient were incorporated into an in‐house treatment planning platform for VMAT. During the optimization, the dose matrix was shifted based on the systematic error, then convolved with a pre‐calculated Gaussian kernel to account for random errors. For each of these patients seven plans were generated using uncertainty data accumulated in 5 fraction increments. Results: The urethra EUD increased by >5Gy when the dose distribution from the static plan was propagated to account for geometrical uncertainties. In contrast, if uncertainties were accounted for in planning, urethra EUD was reduced without compromising CTV coverage (EUD decreased <1.5Gy). For four of five patients, the repositioning data from the first five fractions was sufficient to account for uncertainty in planning. In the proposed biologically‐based optimization inclusive of uncertainties, the PTV is not required. Appropriate dose coverage of the CTV is intrinsically produced by the optimization procedure. Because this coverage is typically tight and patient specific, improved normal tissue sparing was achieved. The rectal EUD was lowered by up to 23Gy compared to static plans that utilize the generic PTV concept. Conclusion: Our approach allows the inclusion of geometrical uncertainties into biologically‐based optimization of IMRT. Partial uncertainty data are sufficient to produce an optimal plan.

[1]  A. Hanlon,et al.  Hypoxic regions exist in human prostate carcinoma. , 1999, Urology.

[2]  A. Hanlon,et al.  Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer. , 1996, Urology.

[3]  M. Keyes,et al.  Urinary incontinence in prostate cancer patients treated with external beam radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  M. Dewhirst,et al.  Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  W. Tomé,et al.  Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes. , 2006, International journal of radiation oncology, biology, physics.

[6]  J. Hendry,et al.  Radiobiology for the Radiologist , 1979, British Journal of Cancer.

[7]  A. Hanlon,et al.  Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study. , 2000 .

[8]  W. J. Morris,et al.  Urethral and periurethral dosimetry in prostate brachytherapy: is there a convenient surrogate? , 2002, International journal of radiation oncology, biology, physics.

[9]  H D Thames,et al.  Fractionation parameters for human tissues and tumors. , 1989, International journal of radiation biology.

[10]  Daniela Thorwarth,et al.  Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.

[11]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[12]  R. Mohan,et al.  Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. , 2002, International journal of radiation oncology, biology, physics.

[13]  R Mohan,et al.  Clinically relevant optimization of 3-D conformal treatments. , 1992, Medical physics.

[14]  R. Nath,et al.  Effects of Continuous Low Dose‐Rate Irradiation: Computer Simulations , 1988, Cell and tissue kinetics.

[15]  Jian Z. Wang,et al.  Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. , 2004, Physics in medicine and biology.

[16]  D J Brenner,et al.  Fractionation and protraction for radiotherapy of prostate carcinoma. , 1999, International journal of radiation oncology, biology, physics.

[17]  J. Fowler,et al.  A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. , 2001, International journal of radiation oncology, biology, physics.

[18]  A. Chatterjee,et al.  Clusters of DNA induced by ionizing radiation: formation of short DNA fragments. I. Theoretical modeling. , 1996, Radiation research.

[19]  P. Fransson,et al.  Prospective evaluation of urinary and intestinal side effects after BeamCath stereotactic dose-escalated radiotherapy of prostate cancer. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Lei Xing,et al.  Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution. , 2005, Medical physics.

[21]  H D Thames,et al.  Time-dose factors in radiotherapy: a review of the human data. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  D. Goodhead,et al.  Modelling of radiation-induced DNA damage: the early physical and chemical event. , 1994, International journal of radiation biology.

[23]  T E Schultheiss,et al.  Models in radiotherapy: volume effects. , 1983, Medical physics.

[24]  M. Dewhirst,et al.  Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. , 1999, American journal of physiology. Heart and circulatory physiology.

[25]  A. Nahum,et al.  The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes. , 2006, Medical physics.

[26]  R. Jaszczak,et al.  The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up. , 2002, International journal of radiation oncology, biology, physics.

[27]  X. Li,et al.  Dose escalation to combat hypoxia in prostate cancer: a radiobiological study on clinical data. , 2006, The British journal of radiology.

[28]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[29]  J. Lyman Complication probability as assessed from dose-volume histograms. , 1985, Radiation research. Supplement.

[30]  T. Puck,et al.  ACTION OF X-RAYS ON MAMMALIAN CELLS , 1956, The Journal of experimental medicine.

[31]  A. Hanlon,et al.  Hypoxia in Human Prostate Carcinoma: An Eppendorf Po2 Study , 2001, American journal of clinical oncology.

[32]  P Baas,et al.  Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. , 2000, International journal of radiation oncology, biology, physics.

[33]  E. Hall,et al.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.

[34]  A Brahme,et al.  Individualizing cancer treatment: biological optimization models in treatment planning and delivery. , 2001, International journal of radiation oncology, biology, physics.

[35]  A. Nahum,et al.  Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio. , 2003, International journal of radiation oncology, biology, physics.

[36]  X Allen Li,et al.  BGRT: biologically guided radiation therapy-the future is fast approaching! , 2007, Medical physics.

[37]  J. Bowsher,et al.  Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  M T Munley,et al.  Incorporation of functional status into dose-volume analysis. , 1999, Medical physics.

[39]  M. Goitein,et al.  Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.

[40]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[41]  J. Battista,et al.  Limitations of a convolution method for modeling geometric uncertainties in radiation therapy. I. The effect of shift invariance. , 2003, Medical physics.

[42]  J. Montie,et al.  Functional anatomy of the prostate: implications for treatment planning. , 2005, International journal of radiation oncology, biology, physics.

[43]  A. Niemierko Reporting and analyzing dose distributions: a concept of equivalent uniform dose. , 1997, Medical physics.

[44]  M. Dewhirst,et al.  Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.

[45]  M. Dewhirst,et al.  Temporal changes in PO2 of R3230AC tumors in Fischer-344 rats. , 1998, International journal of radiation oncology, biology, physics.